Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0002138368-26-000007

VP, Prin. Accounting Officer sold 5,628 shares at an average $30.09 ($169,324)

  • VP, Prin. Accounting Officer acquired 13,647 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Meluzio Michael Vincent · VP, Prin. Accounting Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-13 Exercise or conversion : show line 1 in the form +13,647 54,589 D
2026-08-13 Sale : show line 2 in the form −1,519 $29.37 $44,613 53,070 D
2026-08-13 Sale : show line 3 in the form −4,106 $30.35 $124,617 48,964 D
2026-08-13 Sale : show line 4 in the form −3 $31.13 $93 48,961 D
Open-market sales · 5,628 sh · avg $30.09 · $169,324

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-13 Exercise or conversion : show line 5 in the form Common Stock −13,647 27,295 D
Loading xslF345X06/form4-08172026_100852.xml…